Investor mix
4 investors on record; lead investors include NIH.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Other / undisclosed | 3 | 75% |
Developer of a medical device for neurological conditions
4 investors on record; lead investors include NIH.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 25% |
| Other / undisclosed | 3 | 75% |